Fecal neutrophil gelatinase-associated lipocalin as a biomarker for inflammatory bowel disease-Reference-Cited by-同舟云学术

Fecal neutrophil gelatinase-associated lipocalin as a biomarker for inflammatory bowel disease

Published:2017-01 Issue:1 Volume:32 Page:128-135
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Thorsvik Silje¹²,Damås Jan Kristian¹³,Granlund Atle vB¹⁴,Flo Trude Helen¹,Bergh Kåre⁵⁶,Østvik Ann Elisabet¹²⁴,Sandvik Arne Kristian¹²⁴

Affiliation:

1. Centre of Molecular Inflammation Research, Department of Cancer Research and Molecular Medicine; Norwegian University of Science and Technology; Trondheim Norway

2. Department of Gastroenterology; St. Olav's University Hospital; Trondheim Norway

3. Department of Infectious Diseases; St. Olav's University Hospital; Trondheim Norway

4. Department of Medical Microbiology; St. Olav's University Hospital; Trondheim Norway

5. The Central Norway Regional Health Authority (RHA); Stjørdal Norway

6. Department of Laboratory Medicine, Children's and Women's Health; Norwegian University of Science and Technology; Trondheim Norway

Funder

Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.13598/fullpdf

Reference29 articles.

1. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study;Roseth;Scand. J. Gastroenterol.,1992

2. The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis;Lasson;J. Crohns Colitis,2015

3. Fecal calprotectin correlates more closely with the simple endoscopic score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI;Schoepfer;Am. J. Gastroenterol.,2010

4. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis;Rheenen;BMJ,2010

5. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation;Waugh;Health Technol. Assess.,2013

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipocalin-2-mediated intestinal epithelial cells pyroptosis via NF-κB/NLRP3/GSDMD signaling axis adversely affects inflammation in colitis;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

2. Faecal biomarkers for diagnosis and prediction of disease course in treatment‐naïve patients with IBD;Alimentary Pharmacology & Therapeutics;2024-07-12

3. Unraveling the fatigue puzzle: insights into the pathogenesis and management of IBD-related fatigue including the role of the gut-brain axis;Frontiers in Medicine;2024-07-03

4. Fecal, Blood, and Urinary Biomarkers in Inflammatory Bowel Diseases;Journal of Translational Gastroenterology;2024-06-28

5. Fecal and Serum Granulocyte Protein Levels in Inflammatory Bowel Disease and Irritable Bowel Syndrome and Their Relation to Disease Activity;Clinical and Translational Gastroenterology;2024-06-26